Osseointegration	B:C0079949
behavior	O
of	O
novel	O
Ti	O
-Nb	I:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
for	O
dental	O
implants	I:C0011373
:	O
an	O
in	O
vivo	I:C1515655
study	O

Osseointegration	O
behavior	O
of	O
novel	O
Ti	B:C0011323
-Nb	I:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
for	O
dental	O
implants	I:C0011373
:	O
an	O
in	O
vivo	I:C1515655
study	O

Osseointegration	O
behavior	O
of	O
novel	O
Ti	O
-Nb	I:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
for	O
dental	B:C0011373
implants	I:C0011373
:	O
an	O
in	O
vivo	I:C1515655
study	O

Osseointegration	O
behavior	O
of	O
novel	O
Ti	O
-Nb	I:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
for	O
dental	O
implants	I:C0011373
:	O
an	O
in	B:C1515655
vivo	I:C1515655
study	O

Osseointegration	O
behavior	O
of	O
novel	O
Ti	O
-Nb	I:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
for	O
dental	O
implants	I:C0011373
:	O
an	O
in	O
vivo	I:C1515655
study	B:C2603343

This	O
study	O
aimed	O
to	O
evaluate	B:C0220825
the	O
effects	O
of	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
on	O
mineral	O
apposition	O
rate	O
and	O
new	O
BIC	O
contact	O
in	O
rabbits	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
effects	O
of	O
Ti-Nb	B:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
on	O
mineral	O
apposition	O
rate	O
and	O
new	O
BIC	O
contact	O
in	O
rabbits	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
effects	O
of	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	B:C0011373
on	O
mineral	O
apposition	O
rate	O
and	O
new	O
BIC	O
contact	O
in	O
rabbits	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
effects	O
of	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
on	O
mineral	O
apposition	O
rate	O
and	O
new	O
BIC	O
contact	O
in	O
rabbits	B:C3887509
.	O

Twelve	O
Ti-Nb	B:C0011323
-	I:C0011323
Zr-Ta-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
were	O
fabricated	O
and	O
placed	O
into	O
the	O
right	O
femur	O
sites	O
in	O
six	O
rabbits	O
,	O
and	O
commercially	O
pure	O
titanium	O
implants	O
were	O
used	O
as	O
controls	O
in	O
the	O
left	O
femur	O
.	O

Twelve	O
Ti-Nb	O
-	I:C0011323
Zr-Ta-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	B:C0011373
were	O
fabricated	O
and	O
placed	O
into	O
the	O
right	O
femur	O
sites	O
in	O
six	O
rabbits	O
,	O
and	O
commercially	O
pure	O
titanium	O
implants	O
were	O
used	O
as	O
controls	O
in	O
the	O
left	O
femur	O
.	O

Twelve	O
Ti-Nb	O
-	I:C0011323
Zr-Ta-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
were	O
fabricated	O
and	O
placed	B:C1533810
into	O
the	O
right	O
femur	O
sites	O
in	O
six	O
rabbits	O
,	O
and	O
commercially	O
pure	O
titanium	O
implants	O
were	O
used	O
as	O
controls	O
in	O
the	O
left	O
femur	O
.	O

Twelve	O
Ti-Nb	O
-	I:C0011323
Zr-Ta-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
were	O
fabricated	O
and	O
placed	O
into	O
the	O
right	B:C0444532
femur	O
sites	O
in	O
six	O
rabbits	O
,	O
and	O
commercially	O
pure	O
titanium	O
implants	O
were	O
used	O
as	O
controls	O
in	O
the	O
left	O
femur	O
.	O

Twelve	O
Ti-Nb	O
-	I:C0011323
Zr-Ta-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
were	O
fabricated	O
and	O
placed	O
into	O
the	O
right	O
femur	B:C0015811
sites	O
in	O
six	O
rabbits	O
,	O
and	O
commercially	O
pure	O
titanium	O
implants	O
were	O
used	O
as	O
controls	O
in	O
the	O
left	O
femur	O
.	O

Twelve	O
Ti-Nb	O
-	I:C0011323
Zr-Ta-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
were	O
fabricated	O
and	O
placed	O
into	O
the	O
right	O
femur	O
sites	B:C1515974
in	O
six	O
rabbits	O
,	O
and	O
commercially	O
pure	O
titanium	O
implants	O
were	O
used	O
as	O
controls	O
in	O
the	O
left	O
femur	O
.	O

Twelve	O
Ti-Nb	O
-	I:C0011323
Zr-Ta-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
were	O
fabricated	O
and	O
placed	O
into	O
the	O
right	O
femur	O
sites	O
in	O
six	O
rabbits	B:C3887509
,	O
and	O
commercially	O
pure	O
titanium	O
implants	O
were	O
used	O
as	O
controls	O
in	O
the	O
left	O
femur	O
.	O

Twelve	O
Ti-Nb	O
-	I:C0011323
Zr-Ta-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
were	O
fabricated	O
and	O
placed	O
into	O
the	O
right	O
femur	O
sites	O
in	O
six	O
rabbits	O
,	O
and	O
commercially	O
pure	O
titanium	B:C0040302
implants	O
were	O
used	O
as	O
controls	O
in	O
the	O
left	O
femur	O
.	O

Twelve	O
Ti-Nb	O
-	I:C0011323
Zr-Ta-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
were	O
fabricated	O
and	O
placed	O
into	O
the	O
right	O
femur	O
sites	O
in	O
six	O
rabbits	O
,	O
and	O
commercially	O
pure	O
titanium	O
implants	B:C0011373
were	O
used	O
as	O
controls	O
in	O
the	O
left	O
femur	O
.	O

Twelve	O
Ti-Nb	O
-	I:C0011323
Zr-Ta-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
were	O
fabricated	O
and	O
placed	O
into	O
the	O
right	O
femur	O
sites	O
in	O
six	O
rabbits	O
,	O
and	O
commercially	O
pure	O
titanium	O
implants	O
were	O
used	O
as	O
controls	O
in	O
the	O
left	B:C0443246
femur	O
.	O

Twelve	O
Ti-Nb	O
-	I:C0011323
Zr-Ta-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
were	O
fabricated	O
and	O
placed	O
into	O
the	O
right	O
femur	O
sites	O
in	O
six	O
rabbits	O
,	O
and	O
commercially	O
pure	O
titanium	O
implants	O
were	O
used	O
as	O
controls	O
in	O
the	O
left	O
femur	B:C0015811
.	O

Tetracycline	B:C0039644
and	O
alizarin	O
red	I:C0051165
were	O
administered	O
3	O
weeks	O
and	O
1	O
week	O
before	O
euthanization	O
,	O
respectively	O
.	O

Tetracycline	O
and	O
alizarin	B:C0051165
red	I:C0051165
were	O
administered	O
3	O
weeks	O
and	O
1	O
week	O
before	O
euthanization	O
,	O
respectively	O
.	O

Tetracycline	O
and	O
alizarin	O
red	I:C0051165
were	O
administered	O
3	O
weeks	O
and	O
1	O
week	O
before	O
euthanization	B:C1136183
,	O
respectively	O
.	O

At	O
4	O
weeks	O
and	O
8	O
weeks	O
after	O
implantation	B:C0011370
,	O
animals	O
were	O
euthanized	O
,	O
respectively	O
.	O

At	O
4	O
weeks	O
and	O
8	O
weeks	O
after	O
implantation	O
,	O
animals	B:C0003062
were	O
euthanized	O
,	O
respectively	O
.	O

Surface	B:C0205148
characterization	O
and	O
implant	O
-	O
bone	O
contact	O
surface	O
analysis	O
were	O
performed	O
by	O
using	O
a	O
scanning	O
electron	I:C0262878
microscope	I:C0262878
and	O
an	O
energy	O
dispersive	I:C0025080
X	I:C0025080
-	I:C0025080
ray	I:C0025080
detector	I:C0025080
.	O

Surface	O
characterization	O
and	O
implant	O
-	O
bone	O
contact	O
surface	B:C0205148
analysis	O
were	O
performed	O
by	O
using	O
a	O
scanning	O
electron	I:C0262878
microscope	I:C0262878
and	O
an	O
energy	O
dispersive	I:C0025080
X	I:C0025080
-	I:C0025080
ray	I:C0025080
detector	I:C0025080
.	O

Surface	O
characterization	O
and	O
implant	O
-	O
bone	O
contact	O
surface	O
analysis	B:C0936012
were	O
performed	O
by	O
using	O
a	O
scanning	O
electron	I:C0262878
microscope	I:C0262878
and	O
an	O
energy	O
dispersive	I:C0025080
X	I:C0025080
-	I:C0025080
ray	I:C0025080
detector	I:C0025080
.	O

Surface	O
characterization	O
and	O
implant	O
-	O
bone	O
contact	O
surface	O
analysis	O
were	O
performed	O
by	O
using	O
a	O
scanning	B:C0262878
electron	I:C0262878
microscope	I:C0262878
and	O
an	O
energy	O
dispersive	I:C0025080
X	I:C0025080
-	I:C0025080
ray	I:C0025080
detector	I:C0025080
.	O

Surface	O
characterization	O
and	O
implant	O
-	O
bone	O
contact	O
surface	O
analysis	O
were	O
performed	O
by	O
using	O
a	O
scanning	O
electron	I:C0262878
microscope	I:C0262878
and	O
an	O
energy	B:C0025080
dispersive	I:C0025080
X	I:C0025080
-	I:C0025080
ray	I:C0025080
detector	I:C0025080
.	O

Mineral	O
apposition	O
rate	O
was	O
evaluated	B:C0220825
using	O
a	O
confocal	O
laser	I:C0242841
scanning	I:C0242841
microscope	I:C0242841
.	O

Mineral	O
apposition	O
rate	O
was	O
evaluated	O
using	O
a	O
confocal	B:C0242841
laser	I:C0242841
scanning	I:C0242841
microscope	I:C0242841
.	O

Toluidine	B:C0523203
blue	I:C0523203
staining	I:C0523203
was	O
performed	O
on	O
undecalcified	O
sections	O
for	O
histology	O
and	O
histomorphology	O
evaluation	O
.	O

Toluidine	O
blue	I:C0523203
staining	I:C0523203
was	O
performed	O
on	O
undecalcified	B:C0243095
sections	O
for	O
histology	O
and	O
histomorphology	O
evaluation	O
.	O

Toluidine	O
blue	I:C0523203
staining	I:C0523203
was	O
performed	O
on	O
undecalcified	O
sections	O
for	O
histology	B:C0019638
and	O
histomorphology	O
evaluation	O
.	O

Scanning	B:C0262878
electron	I:C0262878
microscope	I:C0262878
and	O
histomorphology	O
observation	O
revealed	O
a	O
direct	O
contact	O
between	O
implants	O
and	O
bone	O
of	O
all	O
groups	O
.	O

Scanning	O
electron	I:C0262878
microscope	I:C0262878
and	O
histomorphology	O
observation	O
revealed	O
a	O
direct	O
contact	O
between	O
implants	B:C0011373
and	O
bone	O
of	O
all	O
groups	O
.	O

Scanning	O
electron	I:C0262878
microscope	I:C0262878
and	O
histomorphology	O
observation	O
revealed	O
a	O
direct	O
contact	O
between	O
implants	O
and	O
bone	B:C0262950
of	O
all	O
groups	O
.	O

After	O
a	O
healing	B:C0043240
period	O
of	O
4	O
weeks	O
,	O
Ti-Nb	O
-	I:C0011323
Zr-Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
showed	O
significantly	O
higher	O
mineral	O
apposition	O
rate	O
compared	O
to	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
<	O
0.05	O
)	O
,	O
whereas	O
there	O
was	O
no	O
significant	I:C1273937
difference	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
>	O
0.05	O
)	O
at	O
8	O
weeks	O
.	O

After	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
,	O
Ti-Nb	B:C0011323
-	I:C0011323
Zr-Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
showed	O
significantly	O
higher	O
mineral	O
apposition	O
rate	O
compared	O
to	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
<	O
0.05	O
)	O
,	O
whereas	O
there	O
was	O
no	O
significant	I:C1273937
difference	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
>	O
0.05	O
)	O
at	O
8	O
weeks	O
.	O

After	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
,	O
Ti-Nb	O
-	I:C0011323
Zr-Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	B:C0011373
showed	O
significantly	O
higher	O
mineral	O
apposition	O
rate	O
compared	O
to	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
<	O
0.05	O
)	O
,	O
whereas	O
there	O
was	O
no	O
significant	I:C1273937
difference	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
>	O
0.05	O
)	O
at	O
8	O
weeks	O
.	O

After	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
,	O
Ti-Nb	O
-	I:C0011323
Zr-Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
showed	O
significantly	O
higher	O
mineral	O
apposition	O
rate	O
compared	O
to	O
commercially	O
pure	O
titanium	B:C0040302
implants	O
(	O
P	O
<	O
0.05	O
)	O
,	O
whereas	O
there	O
was	O
no	O
significant	I:C1273937
difference	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
>	O
0.05	O
)	O
at	O
8	O
weeks	O
.	O

After	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
,	O
Ti-Nb	O
-	I:C0011323
Zr-Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
showed	O
significantly	O
higher	O
mineral	O
apposition	O
rate	O
compared	O
to	O
commercially	O
pure	O
titanium	O
implants	B:C0011373
(	O
P	O
<	O
0.05	O
)	O
,	O
whereas	O
there	O
was	O
no	O
significant	I:C1273937
difference	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
>	O
0.05	O
)	O
at	O
8	O
weeks	O
.	O

After	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
,	O
Ti-Nb	O
-	I:C0011323
Zr-Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
showed	O
significantly	O
higher	O
mineral	O
apposition	O
rate	O
compared	O
to	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
<	O
0.05	O
)	O
,	O
whereas	O
there	O
was	O
no	B:C1273937
significant	I:C1273937
difference	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
>	O
0.05	O
)	O
at	O
8	O
weeks	O
.	O

After	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
,	O
Ti-Nb	O
-	I:C0011323
Zr-Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
showed	O
significantly	O
higher	O
mineral	O
apposition	O
rate	O
compared	O
to	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
<	O
0.05	O
)	O
,	O
whereas	O
there	O
was	O
no	O
significant	I:C1273937
difference	O
between	O
Ti-Nb	B:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
>	O
0.05	O
)	O
at	O
8	O
weeks	O
.	O

After	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
,	O
Ti-Nb	O
-	I:C0011323
Zr-Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
showed	O
significantly	O
higher	O
mineral	O
apposition	O
rate	O
compared	O
to	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
<	O
0.05	O
)	O
,	O
whereas	O
there	O
was	O
no	O
significant	I:C1273937
difference	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	B:C0011373
and	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
>	O
0.05	O
)	O
at	O
8	O
weeks	O
.	O

After	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
,	O
Ti-Nb	O
-	I:C0011323
Zr-Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
showed	O
significantly	O
higher	O
mineral	O
apposition	O
rate	O
compared	O
to	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
<	O
0.05	O
)	O
,	O
whereas	O
there	O
was	O
no	O
significant	I:C1273937
difference	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	B:C0040302
implants	O
(	O
P	O
>	O
0.05	O
)	O
at	O
8	O
weeks	O
.	O

After	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
,	O
Ti-Nb	O
-	I:C0011323
Zr-Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
showed	O
significantly	O
higher	O
mineral	O
apposition	O
rate	O
compared	O
to	O
commercially	O
pure	O
titanium	O
implants	O
(	O
P	O
<	O
0.05	O
)	O
,	O
whereas	O
there	O
was	O
no	O
significant	I:C1273937
difference	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	B:C0011373
(	O
P	O
>	O
0.05	O
)	O
at	O
8	O
weeks	O
.	O

No	B:C1273937
significant	I:C1273937
difference	O
of	O
bone	O
-	O
to	O
-	O
implant	O
contact	O
was	O
observed	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	O
implants	O
after	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
and	O
8	O
weeks	O
.	O

No	O
significant	I:C1273937
difference	O
of	O
bone	O
-	O
to	O
-	O
implant	O
contact	O
was	O
observed	O
between	O
Ti-Nb	B:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	O
implants	O
after	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
and	O
8	O
weeks	O
.	O

No	O
significant	I:C1273937
difference	O
of	O
bone	O
-	O
to	O
-	O
implant	O
contact	O
was	O
observed	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	B:C0011373
and	O
commercially	O
pure	O
titanium	O
implants	O
implants	O
after	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
and	O
8	O
weeks	O
.	O

No	O
significant	I:C1273937
difference	O
of	O
bone	O
-	O
to	O
-	O
implant	O
contact	O
was	O
observed	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	B:C0040302
implants	O
implants	O
after	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
and	O
8	O
weeks	O
.	O

No	O
significant	I:C1273937
difference	O
of	O
bone	O
-	O
to	O
-	O
implant	O
contact	O
was	O
observed	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	B:C0011373
implants	O
after	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
and	O
8	O
weeks	O
.	O

No	O
significant	I:C1273937
difference	O
of	O
bone	O
-	O
to	O
-	O
implant	O
contact	O
was	O
observed	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	O
implants	B:C0011373
after	O
a	O
healing	O
period	O
of	O
4	O
weeks	O
and	O
8	O
weeks	O
.	O

No	O
significant	I:C1273937
difference	O
of	O
bone	O
-	O
to	O
-	O
implant	O
contact	O
was	O
observed	O
between	O
Ti-Nb	O
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
and	O
commercially	O
pure	O
titanium	O
implants	O
implants	O
after	O
a	O
healing	B:C0043240
period	O
of	O
4	O
weeks	O
and	O
8	O
weeks	O
.	O

This	O
study	O
showed	O
that	O
Ti	B:C0011323
-Nb	I:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
could	O
establish	O
a	O
close	O
direct	O
contact	O
comparedto	O
commercially	O
pure	O
titanium	O
implants	O
implants	O
,	O
improved	O
mineral	O
matrix	O
apposition	O
rate	O
,	O
and	O
may	O
someday	O
be	O
an	O
alternative	O
as	O
a	O
material	O
for	O
dental	O
implants	I:C0011373
.	O

This	O
study	O
showed	O
that	O
Ti	O
-Nb	I:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	B:C0011373
could	O
establish	O
a	O
close	O
direct	O
contact	O
comparedto	O
commercially	O
pure	O
titanium	O
implants	O
implants	O
,	O
improved	O
mineral	O
matrix	O
apposition	O
rate	O
,	O
and	O
may	O
someday	O
be	O
an	O
alternative	O
as	O
a	O
material	O
for	O
dental	O
implants	I:C0011373
.	O

This	O
study	O
showed	O
that	O
Ti	O
-Nb	I:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
could	O
establish	O
a	O
close	O
direct	O
contact	O
comparedto	O
commercially	O
pure	O
titanium	B:C0040302
implants	O
implants	O
,	O
improved	O
mineral	O
matrix	O
apposition	O
rate	O
,	O
and	O
may	O
someday	O
be	O
an	O
alternative	O
as	O
a	O
material	O
for	O
dental	O
implants	I:C0011373
.	O

This	O
study	O
showed	O
that	O
Ti	O
-Nb	I:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
could	O
establish	O
a	O
close	O
direct	O
contact	O
comparedto	O
commercially	O
pure	O
titanium	O
implants	B:C0011373
implants	O
,	O
improved	O
mineral	O
matrix	O
apposition	O
rate	O
,	O
and	O
may	O
someday	O
be	O
an	O
alternative	O
as	O
a	O
material	O
for	O
dental	O
implants	I:C0011373
.	O

This	O
study	O
showed	O
that	O
Ti	O
-Nb	I:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
could	O
establish	O
a	O
close	O
direct	O
contact	O
comparedto	O
commercially	O
pure	O
titanium	O
implants	O
implants	B:C0011373
,	O
improved	O
mineral	O
matrix	O
apposition	O
rate	O
,	O
and	O
may	O
someday	O
be	O
an	O
alternative	O
as	O
a	O
material	O
for	O
dental	O
implants	I:C0011373
.	O

This	O
study	O
showed	O
that	O
Ti	O
-Nb	I:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
could	O
establish	O
a	O
close	O
direct	O
contact	O
comparedto	O
commercially	O
pure	O
titanium	O
implants	O
implants	O
,	O
improved	B:C0184511
mineral	O
matrix	O
apposition	O
rate	O
,	O
and	O
may	O
someday	O
be	O
an	O
alternative	O
as	O
a	O
material	O
for	O
dental	O
implants	I:C0011373
.	O

This	O
study	O
showed	O
that	O
Ti	O
-Nb	I:C0011323
-	I:C0011323
Zr	I:C0011323
-	I:C0011323
Ta	I:C0011323
-	I:C0011323
Si	I:C0011323
alloy	I:C0011323
implants	O
could	O
establish	O
a	O
close	O
direct	O
contact	O
comparedto	O
commercially	O
pure	O
titanium	O
implants	O
implants	O
,	O
improved	O
mineral	O
matrix	O
apposition	O
rate	O
,	O
and	O
may	O
someday	O
be	O
an	O
alternative	O
as	O
a	O
material	O
for	O
dental	B:C0011373
implants	I:C0011373
.	O

